focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 51.50
Ask: 54.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.825%)
Open: 53.00
High: 53.00
Low: 53.00
Prev. Close: 53.00
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

26 Oct 2017 16:30

RNS Number : 7583U
Baronsmead Venture Trust PLC
26 October 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD VENTURE TRUST PLC

26 October 2017

Issue of New Shares pursuant to the Offer for Subscription

The Board of Baronsmead Venture Trust plc (the "Company") is pleased to announce that the Company has raised gross proceeds of approximately £18.2 million pursuant to the offer for subscription (the "Offer") set out in the prospectus published by the Company on 4 October 2017 (the "Prospectus").

New Shares issued under the Offer will be issued at an issue price of 94.80 pence and 19,228,312 New Shares in aggregate will be issued pursuant to the Offer. The issue price has been calculated by dividing the Company's latest published Net Asset Value of 91.90 pence as at 30 September 2017 by 0.97 in accordance with the pricing formula set out in the Prospectus.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 31 October 2017.

As set out in the Prospectus the Company will carry out a second allotment of New Shares pursuant to the Offer on 15 November 2017. Shareholders and new investors who wish to participate in the Offer have until 12 noon on 15 November 2017 to return their completed application forms to the Receiving Agent. The Company will not utilise the over allotment facility in relation to the Offer.

It is expected that share certificates and tax certificates in respect of the New Shares will be issued to the relevant Shareholders on 2 November 2017.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of New Shares pursuant to the Offer, the Company will have 203,352,997 Ordinary Shares in issue (of which 11,103,819 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 192,249,178 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMMZGKVMGNZM
Date   Source Headline
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation
5th May 20235:30 pmRNSNet Asset Value(s)
4th May 20231:00 pmRNSNet Asset Value(s)
2nd May 202312:57 pmRNSTotal Voting Rights
5th Apr 20236:21 pmRNSTransaction in Own Shares
3rd Apr 20233:47 pmRNSAllotment of Shares
3rd Apr 202311:09 amRNSTotal Voting Rights
30th Mar 202312:00 pmRNSNet Asset Value(s)
14th Mar 20234:54 pmRNSDirector/PDMR Shareholding
14th Mar 20234:27 pmRNSAllotment of Shares
10th Mar 20239:57 amRNSUpdate on Fundraising
9th Mar 20236:26 pmRNSTransaction in Own Shares
6th Mar 20234:45 pmRNSNet Asset Value(s)
1st Mar 20232:22 pmRNSTotal Voting Rights
22nd Feb 20237:00 amRNSUpdate on Fundraising
14th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20235:00 pmRNSNet Asset Value(s)
1st Feb 20233:54 pmRNSResult of AGM
30th Jan 20235:30 pmRNSDirector/PDMR Shareholding
30th Jan 20235:28 pmRNSDirector/PDMR Shareholding
30th Jan 20235:23 pmRNSDirector/PDMR Shareholding
30th Jan 20233:07 pmRNSAllotment of Shares
27th Jan 202311:30 amRNSNet Asset Value(s)
3rd Jan 20234:49 pmRNSTotal Voting Rights
29th Dec 20224:56 pmRNSTransaction in Own Shares
16th Dec 202212:45 pmRNSPublication of a Prospectus
12th Dec 20224:37 pmRNSTransaction in Own Shares
6th Dec 20225:30 pmRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSAnnual Financial Report
7th Nov 202211:30 amRNSNet Asset Value(s)
14th Oct 20224:45 pmRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTotal Voting Rights
29th Sep 20226:03 pmRNSTransaction in Own Shares
13th Sep 20226:08 pmRNSTransaction in Own Shares
6th Sep 20225:45 pmRNSNet Asset Value(s)
1st Sep 20225:52 pmRNSTotal Voting Rights
16th Aug 20224:49 pmRNSTransaction in Own Shares
12th Aug 202211:44 amRNSIntention to Fundraise
4th Aug 20226:00 pmRNSNet Asset Value(s)
20th Jul 20227:00 amRNSNet Asset Value(s)
1st Jul 20224:46 pmRNSTotal Voting Rights
15th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20223:15 pmRNSNet Asset Value(s)
27th May 20227:00 amRNSHalf-year Report
6th May 20223:15 pmRNSNet Asset Value(s)
3rd May 20223:09 pmRNSTotal Voting Rights
25th Apr 20226:03 pmRNSTransaction in Own Shares
14th Apr 20223:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.